Clinical proof of concept for a safe and effective NF-?B-targeting strategy in multiple myeloma. (2019)
Attributed to:
Treating Multiple Myeloma by Targeting the NF-Kappa-B Pathway with Gadd45-Beta/MKK7 Inhibitors
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/bjh.15569
PubMed Identifier: 30255568
Publication URI: http://europepmc.org/abstract/MED/30255568
Type: Journal Article/Review
Volume: 185
Parent Publication: British journal of haematology
Issue: 3
ISSN: 0007-1048